List view / Grid view
26 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The EMA is launching a survey to gather information from companies on their Brexit preparedness plans and identify any particular concerns with regard to medicines supply that may impact public or animal health...
23 January 2018 | By ROMIL
When you need the ultimate quality, take a look at ROMIL-UpS™ ultra lc solvents and eluants. ROMIL‑UpS™ ultra lc solvents and eluant mixes have been developed to address the challenging requirements of critical analytical applications, such as LC-MS and UHPLC, offering the utmost purity for today’s sensitive instrumentation...
19 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Despite providing incentives to drug manufacturers to encourage the study of medications in children, few approved drugs include safe dosing information for obese children...
17 January 2018 | By Gilberto Dalmaso and Frank Panofen - Particle Measuring Systems
Quality by Design (QbD) is a method approach to developing a quality control system using predetermined objectives. It uses the foundations of risk management and science to ensure a repeatable process to manufacture high-quality products. In 2002, the FDA launched QbD as part of its innovation initiative. This paper outlines…
16 January 2018 | By European Pharmaceutical Review
This supplement contains a collection of application notes and whitepapers from some of the leading suppliers to the pharmaceutical industry...
15 January 2018 | By European Pharmaceutical Review
This In-Depth Focus looks at QbD and PAT for cutting biopharma attrition rates as well as continuous freeze-drying technology for biopharma products...
12 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
FDA acts to protect children from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labelling to limit paediatrics use...
3 January 2018 | By Dave Elder, Gene Pacowski, Peter Nelson, Stephen Tindal
Particle size reduction is a fast and cost-effective answer to increasing the exposure of poorly soluble oral drugs by increasing surface area and thereby improving dissolution rate. This approach will only work for DCS IIa1 drugs where dissolution rate is the rate-limiting factor for absorption. This may be applicable to…
20 December 2017 | By Steve Bremer (European Pharmaceutical Review)
Disclosure rate of industry-sponsored clinical trials at 12 months has significantly improved year on year from 71% in 2009 to 93% in 2014, according to ABPI-sponsored study.
15 December 2017 | By Arathi Kizhedath, Jarka Glassey
QbD and PAT could revolutionise the way biopharma industries operate by cutting down their attrition rates, which could drastically change their business model. This article considers the issues involved.
14 December 2017 | By European Pharmaceutical Review
This issue celebrates European Pharmaceutical Review's 21st birthday through 21 interviews with leading lights from across the pharmaceutical industry...
14 December 2017 | By Wickham Laboratories
For certain product types, there is a requirement for testing to determine the absence of certain microorganisms...
14 December 2017 | By Agilent Technologies
Plastic packaging systems for pharmaceutical use include, but are not limited to bags, bottles, vials, ampoules, cartridges, dry powder and metered dose inhalers, syringes, blisters, pouches and their associated closures and secondary components like labels and printing overpouches...
13 December 2017 | By Ocean Optics
Various sources estimate that more than 125 million people worldwide wear contact lenses – their popularity having grown appreciably as lenses have become safer and more effective...
13 December 2017 | By Metrohm
Drug analysis needs to be cost effective without compromising on accuracy...
Send this to a friend
Follow: